Postural Instability in Progressive Supranuclear Palsy
1 other identifier
observational
36
1 country
1
Brief Summary
The purpose of this study is to better understand why individuals with Progressive Supranuclear Palsy (PSP) fall. Understanding the mechanism of gait and balance dysfunction in individuals with PSP may provide us with important early diagnostic tools, allowing for earlier identification of mobility problems and to better evaluate medical therapies aimed at improving motor disability. The investigators will recruit 10 PSP, 10 PD and 10 healthy controls for the study. All subjects will be asked to come to the OHSU clinic at the Center for Health and Healing for an initial screening visit. They will meet with the primary investigator to conduct a brief interview and physical examination. In addition, they will be asked to answer questions regarding current and past medical illness, how often they fall and what kinds of medications they are on. Subjects who agree to participate will come to the Oregon Clinical and Translational Research Institute (OCTRI) at OHSU for balance testing. Subjects will be asked to stand or sit on a movable platform with eyes open or closed. Prior to standing on the platform, the investigators will place 6 small sensors on body which are held in place by velcro straps (one on each wrist, ankles, chest and lower back). The platform will then be moved (tilt or slide) while subjects try to keep their balance. During all of the balance tests described above, body movements will be recorded from the sensors on the subjects' body. This data is directly recorded by a computer and analyzed to help us gain better understanding of the subjects' posture and their ability to remain up right.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
March 22, 2012
CompletedFirst Posted
Study publicly available on registry
March 26, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2013
CompletedSeptember 13, 2019
September 1, 2019
1.4 years
March 22, 2012
September 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relative contributions of vestibular and visual information to postural control in PSP
To gage the relative contributions of vestibular and visual information to postural control in PSP we will measure body sway using two different tests (LOS and SOT) while a patient stands on a movable force plate within a movable visual surround.
Single visit. 2 hours.
Secondary Outcomes (3)
Postural Response Latencies
Single visit. 2 hours.
Gait patterns and postural transitions
Single visit. 10 minutes.
Perception of vertical and horizontal references
Single visit. 2 hours.
Study Arms (3)
Progressive Supranuclear Palsy
Patients with a diagnosis of probable or possible PSP as defined by the National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS-SPSP) diagnostic criteria.
Parkinson's Disease
Idiopathic PD according to the UK Parkinson"s Disease Society Brain Bank Clinical Diagnosis Criteria (UKPDSBBCDC)
Healthy Control
Eligibility Criteria
OHSU Movement Disorders Clinic Volunteers from the community (Portland, Oregon and surrounding areas)
You may qualify if:
- Diagnosis of probable or possible PSP as defined by the National Institute of Neurological Disorders and Stroke and Society for Progressive Supranuclear Palsy (NINDS-SPSP) diagnostic criteria.
- Be able to ambulate and stand unassisted for 5 minutes
- Be able to cooperate with gait and balance testing
- Be able to give informed consent.
You may not qualify if:
- Cannot exhibit behavior or have dementia that precludes participation in the protocol
- Cannot have medical or orthopedic illness that, in the investigator's opinion, would impact the patient's postural control or ability to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oregon Health and Science University
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bernadette Schoneberg, MD
Oregon Health and Science University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2012
First Posted
March 26, 2012
Study Start
December 1, 2011
Primary Completion
May 10, 2013
Study Completion
May 10, 2013
Last Updated
September 13, 2019
Record last verified: 2019-09